Sharechat Logo

Wynyard shares climb to record after latest Middle East contract signing

Tuesday 7th January 2014 2 Comments

Text too small?

Wynyard Group shares climbed to a record after the intelligence software developer announced its latest contract win in the Middle East.

The stock rose as high as $1.38 and recently traded at $1.36, up 14 percent on the day. It's rated a 'hold' by two analyst recommendations compiled by Reuters, with a median target price of $1.40.

United Arab Emirates money exchange GCC Exchange will use Wynyard's anti-money laundering software to enhance its ability to detect, investigate, and report suspicious activity, the Auckland-based company said in a statement. The new contract, whose value wasn't disclosed, is the first Wynyard has announced this year, and adds to four deals signed off through November and December.

"The continuing good news of the number of contracts they've been picking up is giving a lot of confidence to investors in that stock," said Grant Williamson, a director at Hamilton Hindin Greene in Christchurch. "It's a pretty big move up there and there are not a huge number of participants in the market, so I'm sure we'll see some sellers at some stage."

In November, Wynyard affirmed earlier guidance that it was on track to meet its 2013 sales forecast of $21.5 million, while bringing forward recruitment of new sales and services staff to manage next year's growth pipeline, adding between $1 million and $1.5 million to the forecast operating expenditure of $25 million for the 2013 calendar year.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

On 7 January 2014 at 8:44 pm Xtoff said:
Happy to forego dividends over next 2/3 years if this progress can continue.
On 7 January 2014 at 9:43 pm Dunc said:
So a Xero with actual profits???
Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar eases on technical factors, buoyed by higher dairy prices
RBNZ eyes Westpac Australia money laundering failures
Heritage buys Golden Healthcare; not mystery Metlife suitor
Alliance margins improve as swine fever boosts global meat prices
RBNZ eyes Westpac Australia money laundering failures
Precinct eyes new developments as Commercial Bay keeps to revised schedule
End to Tower's three year dividend drought in sight
Vital Healthcare's manager appoints new independent director
Argosy lifts first-half profit 15.2% on valuation gains
Metlifecare attracts 'credible' bidder after biggest trading day in 2 1/2 years

IRG See IRG research reports